Market Research Report
North America Blood Market Forecast 2019-2028
|Published by||Inkwood Research||Product code||952505|
|Published||Content info||111 Pages
Delivery time: 2-3 business days
|North America Blood Market Forecast 2019-2028|
|Published: August 3, 2020||Content info: 111 Pages||
The North America blood market is anticipated to record a CAGR of 4.08%, during the forecast years of 2019 to 2028. Key factors influencing the market growth include stringent government regulations, the incidence of Chagas disease, and the rise in the adoption of advanced automated blood transfusion systems.
The North America blood market growth is assessed across Canada and the United States. As one of the safest blood systems, Canada's strict guidelines align with the standards set by Health Canada's Food and Drugs Act and Blood Regulations for obtaining blood and plasma. However, the plasma collected in the country is insufficient to fulfill the demand for plasma products. Besides, the majority of plasma products supplied by the Hema-Quebec and the Canadian Blood Services, are purchased from the United States manufacturers, and made from the nation's paid-donor plasma. As a result, plasma received from paid donors is required to meet Canada's demand for plasma products, which subsequently fuel the region's blood market.
Moreover, the increased prevalence of Chagas disease, owing to the immigration of infected persons from areas prone to the parasite, impacts market growth. The infection is primarily transmitted through the feces of blood-sucking bugs, congenital transmission, blood transfusion, organ transplantation, or the ingestion of contaminated foods. Additionally, acute, vector-borne infections are not severe, but may persist throughout the individual's lifetime, often without symptoms.
Some prominent companies in the market include, Abbott Laboratories, Bio-Rad Laboratories Inc, Haemonetics Corporation, Merck & Co Inc, Baxter International Inc, etc.